Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
10.83
-0.16 (-1.46%)
At close: Nov 7, 2025, 4:00 PM EST
10.80
-0.03 (-0.28%)
After-hours: Nov 7, 2025, 6:31 PM EST
Dynavax Technologies Employees
Dynavax Technologies had 405 employees as of December 31, 2024. The number of employees decreased by 3 or -0.74% compared to the previous year.
Employees
405
Change (1Y)
-3
Growth (1Y)
-0.74%
Revenue / Employee
$816,084
Profits / Employee
-$107,163
Market Cap
1.27B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 405 | -3 | -0.74% |
| Dec 31, 2023 | 408 | 57 | 16.24% |
| Dec 31, 2022 | 351 | 40 | 12.86% |
| Dec 31, 2021 | 311 | 66 | 26.94% |
| Dec 31, 2020 | 245 | 14 | 6.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DVAX News
- 3 days ago - Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program - PRNewsWire
- 3 days ago - Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program - PRNewsWire
- 17 days ago - Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025 - PRNewsWire
- 18 days ago - Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial - PRNewsWire
- 5 weeks ago - 3 Of My Favorite Biotech Stocks Under $10 - Seeking Alpha
- 2 months ago - Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference - PRNewsWire
- 2 months ago - Dynavax's shingles vaccine shows similar immune response to GSK's shot in study - Reuters